All In MedTech

Device Trial Radar · NCT01532180

Safety and Efficacy of a Hypoglossal Nerve Implant for the Treatment of Obstructive Sleep Apnea (OSA)

A Pilot Study and Follow Up of the Use of a Hypoglossal Nerve Implant for Treatment of Obstructive Sleep Apnea

Last checked: Nov 19, 2026Latest source record: Aug 12, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

14

Actual

Start

Nov 2009

Primary completion

Dec 2011

Study completion Dec 2011

Sponsor

Lead sponsor
ImThera Medical, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Feb 14, 2012

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 25 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of the study is to determine the safety and preliminary efficacy in patients utilizing the aura6000 System for the treatment of Obstructive Sleep Apnea (OSA).

Conditions

  • Sleep Apnea Syndromes
  • Sleep Apnea, Obstructive
  • Respiration Disorders
  • Signs and Symptoms, Respiratory
  • Syndrome, Obstructive Sleep Apnea

Interventions

  • aura6000 SystemDevice

    The aura6000 device is an implanted hypoglossal nerve stimulator designed to maintain wakeful muscle tone of the tongue during sleep. It is implanted through a short surgical procedure. The implant is programmed to provide the optimal stimulation parameters for the patient. The therapy is controlled by a hand-held remote control allowing the patient to start, stop, and pause the therapy during times of sleep.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean change in AHI measured through in-lab polysomnography (PSG) compared to baseline.Time frame: 3 and 12 months post-implant
  2. Adverse events and Serious Adverse events peri and post-operativelyTime frame: 3 and 12 months post-operative

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Clinique Univ. Saint-Luc

    Brussels, Belgium

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.